Literature DB >> 3494115

Relationships of serum opsonins and complement in human experimental gingivitis.

C A Henry, T Ungchusri, T D Charbeneau, T E Winford.   

Abstract

This study assessed the phagocytosis of polymorphonuclear neutrophils and the opsonic capacity of serum in experimental human gingivitis. Relationships were sought among these two measurements, clinical indices of gingivitis and complement-related opsonins. Measurements of chemiluminescence provided an index of phagocytosis and of opsonic capacity. Test group Plaque Index scores were higher than the control group on Days 7, 14, and 21, while the Gingival Index of the test group was elevated only on Day 21. Phagocytosis of test subjects' PMNs and opsonic capacity of their sera were no different from that of the controls'. Levels of C3 in both nonactivated and activated sera of the test group were significantly lower than that of the control group only on Day 14. In the test group, differences of per cent C3 conversion occurred between Days 14 and 21, and Plaque Index scores were inversely correlated with the order of per cent C3 data on these same days. Our results also indicate that complement contributes significantly to the serum opsonic capacity. The levels of developing plaque and subsequent gingival inflammation are apparently related to the degree of complement activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494115     DOI: 10.1902/jop.1987.58.3.177

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  2 in total

1.  Functional properties of nonhuman primate antibody to Porphyromonas gingivalis.

Authors:  D M Anderson; J L Ebersole; M J Novak
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

2.  Metaproteomics of saliva identifies human protein markers specific for individuals with periodontitis and dental caries compared to orally healthy controls.

Authors:  Daniel Belstrøm; Rosa R Jersie-Christensen; David Lyon; Christian Damgaard; Lars J Jensen; Palle Holmstrup; Jesper V Olsen
Journal:  PeerJ       Date:  2016-09-14       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.